1. Reyataz. Ficha técnica del producto, 2008. European Medicines Agency. Disponible en: http://www.emea.europa.eu/humandocs/Humans/EPAR/reyataz/reyataz.htm.
2. BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents;Robinson;Antimicrob Agents Chemother,2000
3. Synergistic inhibition of protease-inhibitor-resistant HIV type 1 by saquinavir in combination with atazanavir or lopinavir;Dam;Antivir Ther,2007
4. New Orleans: 9th International Workshop on Clinical Pharmacology of HIV Therapy;Zhu,2008
5. Hollow-fiber unit evaluation of a new human immunodeficiency virus type 1 protease inhibitor, BMS-232632, for determination of the linked pharmacodynamic variable;Drusano;J Infect Dis,2001